Rank | Gene Set | Z-score |
---|---|---|
1 | protoporphyrinogen IX metabolic process (GO:0046501) | 8.45335421 |
2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.59323552 |
3 | porphyrin-containing compound biosynthetic process (GO:0006779) | 7.26512381 |
4 | erythrocyte development (GO:0048821) | 7.01291019 |
5 | tetrapyrrole biosynthetic process (GO:0033014) | 6.45159524 |
6 | erythrocyte maturation (GO:0043249) | 6.40254861 |
7 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.11192495 |
8 | porphyrin-containing compound metabolic process (GO:0006778) | 5.98897994 |
9 | heme biosynthetic process (GO:0006783) | 5.87864592 |
10 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.73646251 |
11 | * granulocyte differentiation (GO:0030851) | 5.55547820 |
12 | positive regulation of fibroblast migration (GO:0010763) | 5.53755416 |
13 | positive regulation of histone deacetylation (GO:0031065) | 5.52838960 |
14 | * embryonic hemopoiesis (GO:0035162) | 5.52329883 |
15 | positive regulation of osteoblast proliferation (GO:0033690) | 5.31189986 |
16 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.24639722 |
17 | heme metabolic process (GO:0042168) | 5.04878328 |
18 | * platelet formation (GO:0030220) | 5.02086728 |
19 | positive regulation of erythrocyte differentiation (GO:0045648) | 4.94601548 |
20 | mannose metabolic process (GO:0006013) | 4.94157014 |
21 | * regulation of erythrocyte differentiation (GO:0045646) | 4.89205875 |
22 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.78816411 |
23 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.74770228 |
24 | maternal placenta development (GO:0001893) | 4.68197915 |
25 | tolerance induction (GO:0002507) | 4.58714347 |
26 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.54173765 |
27 | response to methylmercury (GO:0051597) | 4.53566001 |
28 | response to thyroid hormone (GO:0097066) | 4.52540453 |
29 | modulation by virus of host process (GO:0019054) | 4.51648573 |
30 | * myeloid cell development (GO:0061515) | 4.47257311 |
31 | regulation of superoxide anion generation (GO:0032928) | 4.44622530 |
32 | negative regulation of bone mineralization (GO:0030502) | 4.33311141 |
33 | negative regulation of phagocytosis (GO:0050765) | 4.28959406 |
34 | pattern specification involved in kidney development (GO:0061004) | 4.23579064 |
35 | * erythrocyte differentiation (GO:0030218) | 4.19948481 |
36 | thymic T cell selection (GO:0045061) | 4.19776120 |
37 | regulation of cholesterol homeostasis (GO:2000188) | 4.03004309 |
38 | positive regulation of protein deacetylation (GO:0090312) | 3.99547601 |
39 | positive thymic T cell selection (GO:0045059) | 3.93763167 |
40 | receptor catabolic process (GO:0032801) | 3.91248379 |
41 | regulation of histone H3-K27 methylation (GO:0061085) | 3.85379733 |
42 | germ cell migration (GO:0008354) | 3.85214608 |
43 | regulation of transcription regulatory region DNA binding (GO:2000677) | 3.83605609 |
44 | tetrapyrrole metabolic process (GO:0033013) | 3.74186514 |
45 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.70577310 |
46 | negative regulation of biomineral tissue development (GO:0070168) | 3.69539822 |
47 | regulation of extracellular matrix disassembly (GO:0010715) | 3.67560382 |
48 | cellular hyperosmotic response (GO:0071474) | 3.65733877 |
49 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 3.64936347 |
50 | modulation by symbiont of host cellular process (GO:0044068) | 3.64313470 |
51 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.63297237 |
52 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.61667633 |
53 | regulation of histone deacetylation (GO:0031063) | 3.56713906 |
54 | hyaluronan catabolic process (GO:0030214) | 3.52738828 |
55 | purine-containing compound salvage (GO:0043101) | 3.52630137 |
56 | cellular response to virus (GO:0098586) | 3.51847793 |
57 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.51632763 |
58 | apoptotic process involved in morphogenesis (GO:0060561) | 3.49032742 |
59 | response to dexamethasone (GO:0071548) | 3.49017322 |
60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.48352559 |
61 | modulation by symbiont of host immune response (GO:0052553) | 3.48352559 |
62 | positive regulation by symbiont of host defense response (GO:0052509) | 3.48352559 |
63 | modulation by symbiont of host defense response (GO:0052031) | 3.48352559 |
64 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.48352559 |
65 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.48352559 |
66 | positive regulation of extracellular matrix organization (GO:1903055) | 3.48268074 |
67 | cellular response to dexamethasone stimulus (GO:0071549) | 3.46784457 |
68 | histone H4 deacetylation (GO:0070933) | 3.46606606 |
69 | GDP-mannose metabolic process (GO:0019673) | 3.44073314 |
70 | response to laminar fluid shear stress (GO:0034616) | 3.43972327 |
71 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.39827922 |
72 | plasma lipoprotein particle assembly (GO:0034377) | 3.37135695 |
73 | regulation of exit from mitosis (GO:0007096) | 3.34858985 |
74 | oxygen transport (GO:0015671) | 3.32090016 |
75 | positive regulation of T cell apoptotic process (GO:0070234) | 3.31794155 |
76 | protein-lipid complex assembly (GO:0065005) | 3.29534924 |
77 | SMAD protein complex assembly (GO:0007183) | 3.28304131 |
78 | purine nucleotide salvage (GO:0032261) | 3.26928077 |
79 | response to lead ion (GO:0010288) | 3.26422854 |
80 | lysine catabolic process (GO:0006554) | 3.25604031 |
81 | lysine metabolic process (GO:0006553) | 3.25604031 |
82 | positive T cell selection (GO:0043368) | 3.24983445 |
83 | negative regulation of viral release from host cell (GO:1902187) | 3.24935739 |
84 | response to arsenic-containing substance (GO:0046685) | 3.24895731 |
85 | T cell selection (GO:0045058) | 3.23992360 |
86 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.19458853 |
87 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.19053126 |
88 | histone H3-K9 modification (GO:0061647) | 3.17156755 |
89 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.16527840 |
90 | cysteine metabolic process (GO:0006534) | 3.15735184 |
91 | negative regulation of histone methylation (GO:0031061) | 3.11382379 |
92 | histone H3 deacetylation (GO:0070932) | 3.08481345 |
93 | histone H3-K4 trimethylation (GO:0080182) | 3.07487175 |
94 | modulation by virus of host morphology or physiology (GO:0019048) | 3.07334459 |
95 | regulation of response to osmotic stress (GO:0047484) | 3.05830576 |
96 | Peyers patch development (GO:0048541) | 3.05302676 |
97 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.05302676 |
98 | RNA stabilization (GO:0043489) | 3.04686832 |
99 | mRNA stabilization (GO:0048255) | 3.04686832 |
100 | positive regulation of protein dephosphorylation (GO:0035307) | 3.04357774 |
101 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.04037547 |
102 | negative regulation of cholesterol transport (GO:0032375) | 3.03715400 |
103 | negative regulation of sterol transport (GO:0032372) | 3.03715400 |
104 | activation of MAPKKK activity (GO:0000185) | 3.02789178 |
105 | hemoglobin metabolic process (GO:0020027) | 3.02722638 |
106 | ribosomal small subunit biogenesis (GO:0042274) | 3.01578565 |
107 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.00928723 |
108 | negative regulation of granulocyte differentiation (GO:0030853) | 2.99033026 |
109 | response to insecticide (GO:0017085) | 2.96717981 |
110 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.96571467 |
111 | defense response to fungus (GO:0050832) | 2.96015108 |
112 | regulation of granulocyte differentiation (GO:0030852) | 2.92251979 |
113 | histone H3-K4 methylation (GO:0051568) | 2.86839478 |
114 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.86288619 |
115 | positive regulation by host of viral transcription (GO:0043923) | 2.83579493 |
116 | protein insertion into membrane (GO:0051205) | 2.81493450 |
117 | positive regulation of protein kinase C signaling (GO:0090037) | 2.80984297 |
118 | regulation of cholesterol storage (GO:0010885) | 2.80901018 |
119 | platelet aggregation (GO:0070527) | 2.80586208 |
120 | heterochromatin organization (GO:0070828) | 2.80308265 |
121 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79287973 |
122 | gas transport (GO:0015669) | 2.78858725 |
123 | regulation of superoxide metabolic process (GO:0090322) | 2.76436561 |
124 | peptidyl-lysine trimethylation (GO:0018023) | 2.76368502 |
125 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.75575441 |
126 | protein carboxylation (GO:0018214) | 2.74934730 |
127 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.74934730 |
128 | osteoblast development (GO:0002076) | 2.73254129 |
129 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.72815889 |
130 | activation of Rac GTPase activity (GO:0032863) | 2.72521460 |
131 | opioid receptor signaling pathway (GO:0038003) | 2.72114545 |
132 | regulation of chromatin binding (GO:0035561) | 2.71832237 |
133 | regulation of ARF GTPase activity (GO:0032312) | 2.71828518 |
134 | regulation of monocyte differentiation (GO:0045655) | 2.71391347 |
135 | dendritic cell differentiation (GO:0097028) | 2.70782738 |
136 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.70780505 |
137 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.70780505 |
138 | regulation of histone H3-K9 methylation (GO:0051570) | 2.70600941 |
139 | sodium ion export (GO:0071436) | 2.69577149 |
140 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.68872055 |
141 | alpha-linolenic acid metabolic process (GO:0036109) | 2.68671292 |
142 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.68387271 |
143 | regulation of translational termination (GO:0006449) | 2.67653342 |
144 | definitive hemopoiesis (GO:0060216) | 2.67191779 |
145 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.66583868 |
146 | negative regulation of cell size (GO:0045792) | 2.65879512 |
147 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.65829548 |
148 | activation of JUN kinase activity (GO:0007257) | 2.64750235 |
149 | L-phenylalanine catabolic process (GO:0006559) | 2.64112498 |
150 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.64112498 |
151 | folic acid metabolic process (GO:0046655) | 2.63810263 |
152 | negative thymic T cell selection (GO:0045060) | 2.63644401 |
153 | regulation of RNA export from nucleus (GO:0046831) | 2.63637899 |
154 | positive regulation of protein homooligomerization (GO:0032464) | 2.63006089 |
155 | snRNA metabolic process (GO:0016073) | 2.62357022 |
156 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.56145653 |
157 | response to muramyl dipeptide (GO:0032495) | 2.55988097 |
158 | regulation of protein deacetylation (GO:0090311) | 2.54931039 |
159 | viral transcription (GO:0019083) | 2.53918227 |
160 | apoptotic process involved in development (GO:1902742) | 2.52891424 |
161 | cellular response to interleukin-4 (GO:0071353) | 2.50346309 |
162 | histone H3-K9 methylation (GO:0051567) | 2.49959837 |
163 | negative regulation of fatty acid transport (GO:2000192) | 2.49952559 |
164 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.49769602 |
165 | positive regulation of Rap GTPase activity (GO:0032854) | 2.48536751 |
166 | natural killer cell differentiation (GO:0001779) | 2.47240127 |
167 | retinoic acid receptor signaling pathway (GO:0048384) | 2.46068113 |
168 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45120890 |
169 | mitotic G1/S transition checkpoint (GO:0044819) | 2.43618972 |
170 | proline biosynthetic process (GO:0006561) | 2.42955871 |
171 | histone H3 acetylation (GO:0043966) | 2.41728417 |
172 | segment specification (GO:0007379) | 2.41371886 |
173 | NIK/NF-kappaB signaling (GO:0038061) | 2.40286296 |
174 | negative T cell selection (GO:0043383) | 2.39521365 |
175 | regulation of translational fidelity (GO:0006450) | 2.39475923 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.06269121 |
2 | GATA1_22025678_ChIP-Seq_K562_Human | 3.96036062 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.92635587 |
4 | * MYC_22102868_ChIP-Seq_BL_Human | 3.73531393 |
5 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.56419590 |
6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.56085469 |
7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.25416442 |
8 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 3.07558278 |
9 | * GATA1_19941826_ChIP-Seq_K562_Human | 3.00101650 |
10 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.84932757 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.82592557 |
12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.81239671 |
13 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.49922951 |
14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.45192987 |
15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.40924362 |
16 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.30154074 |
17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26041700 |
18 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.23148424 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.16555441 |
20 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.10981494 |
21 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.09498731 |
22 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.05135715 |
23 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.97189671 |
24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89804463 |
25 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88266360 |
26 | * MAF_26560356_Chip-Seq_TH1_Human | 1.86597006 |
27 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86230269 |
28 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.85779172 |
29 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.85243854 |
30 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83023252 |
31 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.79385317 |
32 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.79136535 |
33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.77933152 |
34 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.76796674 |
35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74439133 |
36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.67853079 |
37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66927162 |
38 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.65948670 |
39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65043722 |
40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63787548 |
41 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.63061671 |
42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62598338 |
43 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.61502920 |
44 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58487576 |
45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58270308 |
46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.56584094 |
47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56402811 |
48 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52771129 |
49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.51895361 |
50 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48893573 |
51 | MAF_26560356_Chip-Seq_TH2_Human | 1.46357100 |
52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45443228 |
53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45440880 |
54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44185303 |
55 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.42426626 |
56 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41939304 |
57 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.41874121 |
58 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.41816990 |
59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41480695 |
60 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.41004529 |
61 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.38865075 |
62 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.38529991 |
63 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38507937 |
64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36971835 |
65 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.34199642 |
66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33648150 |
67 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33103539 |
68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.32964033 |
69 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32273380 |
70 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.31470291 |
71 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31403007 |
72 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30312844 |
73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.29665627 |
74 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29090824 |
75 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.28658195 |
76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27944761 |
77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25715977 |
78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21317916 |
79 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.20818855 |
80 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20404846 |
81 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.20404208 |
82 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20002761 |
83 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19770495 |
84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19214924 |
85 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.17771214 |
86 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17490763 |
87 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15533141 |
88 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.14063367 |
89 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.13556897 |
90 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13211339 |
91 | * MYB_26560356_Chip-Seq_TH1_Human | 1.13112035 |
92 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13066163 |
93 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12340547 |
94 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.12285850 |
95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11194751 |
96 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11161016 |
97 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10856196 |
98 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10823936 |
99 | * P68_20966046_ChIP-Seq_HELA_Human | 1.10343623 |
100 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09971461 |
101 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09652458 |
102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08422373 |
103 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08328706 |
104 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07728374 |
105 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06237869 |
106 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05604440 |
107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05334504 |
108 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05225931 |
109 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.04846505 |
110 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.04780082 |
111 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.04321813 |
112 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04178035 |
113 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.04003087 |
114 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03802434 |
115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03780792 |
116 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02874883 |
117 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02713948 |
118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00808181 |
119 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99763757 |
120 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.99562000 |
121 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99277654 |
122 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98465434 |
123 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98056869 |
124 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97857682 |
125 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96862661 |
126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96545712 |
127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96366887 |
128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96019603 |
129 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.96005161 |
130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95969511 |
131 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93711909 |
132 | MYB_26560356_Chip-Seq_TH2_Human | 0.93590589 |
133 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.92884141 |
134 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.92457727 |
135 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92386568 |
136 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92173508 |
137 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90788245 |
138 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90619784 |
139 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90292858 |
140 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88606117 |
141 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88563585 |
142 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.87770532 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003656_abnormal_erythrocyte_physiolo | 6.98124646 |
2 | MP0004147_increased_porphyrin_level | 4.37361459 |
3 | MP0005083_abnormal_biliary_tract | 4.27009738 |
4 | MP0001545_abnormal_hematopoietic_system | 4.23814136 |
5 | MP0005397_hematopoietic_system_phenotyp | 4.23814136 |
6 | MP0002132_abnormal_respiratory_system | 4.09412876 |
7 | MP0003172_abnormal_lysosome_physiology | 3.50939081 |
8 | MP0005451_abnormal_body_composition | 3.50005423 |
9 | MP0003300_gastrointestinal_ulcer | 3.40321166 |
10 | MP0003705_abnormal_hypodermis_morpholog | 3.14377929 |
11 | MP0002139_abnormal_hepatobiliary_system | 3.00319098 |
12 | MP0005360_urolithiasis | 2.93446031 |
13 | MP0003436_decreased_susceptibility_to | 2.59915213 |
14 | MP0005058_abnormal_lysosome_morphology | 2.53935775 |
15 | MP0005377_hearing/vestibular/ear_phenot | 2.50573911 |
16 | MP0003878_abnormal_ear_physiology | 2.50573911 |
17 | MP0001873_stomach_inflammation | 2.47425770 |
18 | MP0003111_abnormal_nucleus_morphology | 2.47354113 |
19 | MP0009840_abnormal_foam_cell | 2.36605273 |
20 | MP0002249_abnormal_larynx_morphology | 2.34798839 |
21 | MP0003191_abnormal_cellular_cholesterol | 2.32316462 |
22 | MP0010352_gastrointestinal_tract_polyps | 2.31440087 |
23 | MP0005085_abnormal_gallbladder_physiolo | 2.24008891 |
24 | MP0004381_abnormal_hair_follicle | 2.22157160 |
25 | MP0003123_paternal_imprinting | 2.12391964 |
26 | MP0000465_gastrointestinal_hemorrhage | 2.09892552 |
27 | MP0009278_abnormal_bone_marrow | 2.02877106 |
28 | MP0002396_abnormal_hematopoietic_system | 2.01609643 |
29 | MP0005310_abnormal_salivary_gland | 1.99620899 |
30 | MP0005409_darkened_coat_color | 1.99180299 |
31 | MP0008260_abnormal_autophagy | 1.94989679 |
32 | MP0005365_abnormal_bile_salt | 1.87998158 |
33 | MP0005464_abnormal_platelet_physiology | 1.79380150 |
34 | MP0003866_abnormal_defecation | 1.73079484 |
35 | MP0000678_abnormal_parathyroid_gland | 1.66463245 |
36 | MP0001348_abnormal_lacrimal_gland | 1.63181901 |
37 | MP0008770_decreased_survivor_rate | 1.61116612 |
38 | MP0010329_abnormal_lipoprotein_level | 1.57775630 |
39 | MP0000685_abnormal_immune_system | 1.54599955 |
40 | MP0000609_abnormal_liver_physiology | 1.49146016 |
41 | MP0000015_abnormal_ear_pigmentation | 1.46116112 |
42 | MP0005636_abnormal_mineral_homeostasis | 1.46008957 |
43 | MP0010307_abnormal_tumor_latency | 1.44340301 |
44 | MP0008872_abnormal_physiological_respon | 1.43838921 |
45 | * MP0002398_abnormal_bone_marrow | 1.42165793 |
46 | MP0000490_abnormal_crypts_of | 1.37392705 |
47 | MP0002089_abnormal_postnatal_growth/wei | 1.36207092 |
48 | * MP0002722_abnormal_immune_system | 1.34270227 |
49 | MP0001849_ear_inflammation | 1.29802425 |
50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.27847778 |
51 | MP0001986_abnormal_taste_sensitivity | 1.27538665 |
52 | MP0006054_spinal_hemorrhage | 1.26515090 |
53 | MP0004808_abnormal_hematopoietic_stem | 1.26233242 |
54 | MP0001502_abnormal_circadian_rhythm | 1.25682955 |
55 | * MP0000689_abnormal_spleen_morphology | 1.25628377 |
56 | MP0003879_abnormal_hair_cell | 1.24817984 |
57 | MP0003806_abnormal_nucleotide_metabolis | 1.22484477 |
58 | MP0000470_abnormal_stomach_morphology | 1.20168787 |
59 | MP0003252_abnormal_bile_duct | 1.18706628 |
60 | MP0001819_abnormal_immune_cell | 1.16075357 |
61 | MP0006082_CNS_inflammation | 1.14797963 |
62 | * MP0000598_abnormal_liver_morphology | 1.14306772 |
63 | MP0001666_abnormal_nutrient_absorption | 1.10487400 |
64 | MP0004130_abnormal_muscle_cell | 1.10284752 |
65 | * MP0009931_abnormal_skin_appearance | 1.07937328 |
66 | MP0001915_intracranial_hemorrhage | 1.06434210 |
67 | MP0004885_abnormal_endolymph | 1.05218733 |
68 | MP0000703_abnormal_thymus_morphology | 1.02890018 |
69 | MP0005025_abnormal_response_to | 1.02483524 |
70 | MP0004858_abnormal_nervous_system | 1.01629243 |
71 | * MP0002429_abnormal_blood_cell | 0.99853850 |
72 | MP0003303_peritoneal_inflammation | 0.99588281 |
73 | MP0009384_cardiac_valve_regurgitation | 0.99300330 |
74 | MP0003077_abnormal_cell_cycle | 0.97103162 |
75 | MP0009333_abnormal_splenocyte_physiolog | 0.96496001 |
76 | MP0003942_abnormal_urinary_system | 0.95686720 |
77 | MP0008775_abnormal_heart_ventricle | 0.95479769 |
78 | MP0001730_embryonic_growth_arrest | 0.95091626 |
79 | MP0009379_abnormal_foot_pigmentation | 0.94940591 |
80 | MP0005000_abnormal_immune_tolerance | 0.94828402 |
81 | MP0002452_abnormal_antigen_presenting | 0.94289558 |
82 | MP0000313_abnormal_cell_death | 0.93305727 |
83 | MP0010094_abnormal_chromosome_stability | 0.92458957 |
84 | MP0009672_abnormal_birth_weight | 0.91981555 |
85 | MP0003943_abnormal_hepatobiliary_system | 0.90045933 |
86 | MP0004185_abnormal_adipocyte_glucose | 0.88554718 |
87 | MP0000538_abnormal_urinary_bladder | 0.88465850 |
88 | MP0000566_synostosis | 0.88108496 |
89 | MP0002019_abnormal_tumor_incidence | 0.87447576 |
90 | MP0000003_abnormal_adipose_tissue | 0.87183282 |
91 | MP0003693_abnormal_embryo_hatching | 0.87179999 |
92 | MP0005319_abnormal_enzyme/_coenzyme | 0.86504501 |
93 | MP0005076_abnormal_cell_differentiation | 0.86369484 |
94 | * MP0002086_abnormal_extraembryonic_tissu | 0.85386312 |
95 | MP0003959_abnormal_lean_body | 0.85159556 |
96 | MP0001661_extended_life_span | 0.81437082 |
97 | MP0002970_abnormal_white_adipose | 0.81135130 |
98 | MP0002405_respiratory_system_inflammati | 0.80922134 |
99 | MP0003453_abnormal_keratinocyte_physiol | 0.80772638 |
100 | MP0001664_abnormal_digestion | 0.80251665 |
101 | MP0005174_abnormal_tail_pigmentation | 0.80006354 |
102 | MP0002138_abnormal_hepatobiliary_system | 0.79061012 |
103 | MP0004947_skin_inflammation | 0.78350310 |
104 | MP0001188_hyperpigmentation | 0.78346110 |
105 | MP0002653_abnormal_ependyma_morphology | 0.77238049 |
106 | MP0004264_abnormal_extraembryonic_tissu | 0.76868792 |
107 | MP0005501_abnormal_skin_physiology | 0.75325175 |
108 | MP0005381_digestive/alimentary_phenotyp | 0.74625851 |
109 | * MP0000716_abnormal_immune_system | 0.74193364 |
110 | MP0002118_abnormal_lipid_homeostasis | 0.74012130 |
111 | MP0000350_abnormal_cell_proliferation | 0.71759063 |
112 | MP0004957_abnormal_blastocyst_morpholog | 0.70910667 |
113 | MP0008961_abnormal_basal_metabolism | 0.70798617 |
114 | MP0006036_abnormal_mitochondrial_physio | 0.70758229 |
115 | MP0005387_immune_system_phenotype | 0.70587900 |
116 | MP0001790_abnormal_immune_system | 0.70587900 |
117 | * MP0002080_prenatal_lethality | 0.70274826 |
118 | MP0002932_abnormal_joint_morphology | 0.68843697 |
119 | MP0002933_joint_inflammation | 0.68489891 |
120 | MP0002877_abnormal_melanocyte_morpholog | 0.68467613 |
121 | MP0010155_abnormal_intestine_physiology | 0.66894957 |
122 | MP0000367_abnormal_coat/_hair | 0.65928150 |
123 | MP0003763_abnormal_thymus_physiology | 0.62571698 |
124 | MP0002419_abnormal_innate_immunity | 0.62563625 |
125 | * MP0000266_abnormal_heart_morphology | 0.61038986 |
126 | MP0009763_increased_sensitivity_to | 0.60994924 |
127 | MP0003115_abnormal_respiratory_system | 0.60570610 |
128 | MP0000858_altered_metastatic_potential | 0.60407939 |
129 | MP0005334_abnormal_fat_pad | 0.60317616 |
130 | MP0005375_adipose_tissue_phenotype | 0.60225570 |
131 | * MP0008469_abnormal_protein_level | 0.59321190 |
132 | MP0001800_abnormal_humoral_immune | 0.58640781 |
133 | MP0001663_abnormal_digestive_system | 0.58556792 |
134 | MP0004510_myositis | 0.58193918 |
135 | * MP0001697_abnormal_embryo_size | 0.57413736 |
136 | MP0003868_abnormal_feces_composition | 0.57355605 |
137 | MP0003329_amyloid_beta_deposits | 0.57325245 |
138 | MP0002088_abnormal_embryonic_growth/wei | 0.57160170 |
139 | MP0006292_abnormal_olfactory_placode | 0.56228527 |
140 | MP0003984_embryonic_growth_retardation | 0.55429090 |
141 | MP0003279_aneurysm | 0.55412277 |
142 | MP0005671_abnormal_response_to | 0.55339928 |
143 | MP0005166_decreased_susceptibility_to | 0.54445107 |
144 | MP0003566_abnormal_cell_adhesion | 0.53421635 |
145 | MP0000477_abnormal_intestine_morphology | 0.53341423 |
146 | MP0002420_abnormal_adaptive_immunity | 0.51521233 |
147 | MP0005666_abnormal_adipose_tissue | 0.50746153 |
148 | * MP0002723_abnormal_immune_serum | 0.50568425 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Poikilocytosis (HP:0004447) | 9.41953914 |
2 | Reticulocytosis (HP:0001923) | 9.31933104 |
3 | Petechiae (HP:0000967) | 7.45059292 |
4 | Polycythemia (HP:0001901) | 6.95288127 |
5 | Abnormality of reticulocytes (HP:0004312) | 6.17475329 |
6 | Short middle phalanx of the 5th finger (HP:0004220) | 6.08661110 |
7 | Prolonged bleeding time (HP:0003010) | 5.20165191 |
8 | Impaired platelet aggregation (HP:0003540) | 4.67944855 |
9 | Abnormal platelet function (HP:0011869) | 4.67944855 |
10 | Hyperbilirubinemia (HP:0002904) | 4.61311065 |
11 | Abnormal number of erythroid precursors (HP:0012131) | 4.42881961 |
12 | Obstructive sleep apnea (HP:0002870) | 4.33003343 |
13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.92810021 |
14 | Increased density of long bones (HP:0006392) | 3.89740021 |
15 | Cholelithiasis (HP:0001081) | 3.89667273 |
16 | Broad palm (HP:0001169) | 3.65785433 |
17 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 3.61537306 |
18 | Short 5th finger (HP:0009237) | 3.60499381 |
19 | Brushfield spots (HP:0001088) | 3.57597592 |
20 | Epistaxis (HP:0000421) | 3.54080421 |
21 | Abnormal gallbladder morphology (HP:0012437) | 3.51354636 |
22 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 3.28493210 |
23 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 3.23042512 |
24 | Thin bony cortex (HP:0002753) | 3.16404187 |
25 | Increased serum ferritin (HP:0003281) | 3.11023049 |
26 | Abnormal gallbladder physiology (HP:0012438) | 3.05698411 |
27 | Cholecystitis (HP:0001082) | 3.05698411 |
28 | Diaphragmatic weakness (HP:0009113) | 3.01007149 |
29 | Deep venous thrombosis (HP:0002625) | 3.00670275 |
30 | Abnormal hemoglobin (HP:0011902) | 2.91992144 |
31 | Broad face (HP:0000283) | 2.89881523 |
32 | Deep palmar crease (HP:0006191) | 2.88861465 |
33 | Hypochromic anemia (HP:0001931) | 2.82576363 |
34 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.80659072 |
35 | Slender build (HP:0001533) | 2.79403652 |
36 | Seborrheic dermatitis (HP:0001051) | 2.77522973 |
37 | Hyperthyroidism (HP:0000836) | 2.77412786 |
38 | Abnormality of iron homeostasis (HP:0011031) | 2.76052988 |
39 | Rectal prolapse (HP:0002035) | 2.69518449 |
40 | Protruding tongue (HP:0010808) | 2.68995717 |
41 | Hypertensive crisis (HP:0100735) | 2.68963479 |
42 | Abnormality of the thoracic spine (HP:0100711) | 2.64200362 |
43 | Insomnia (HP:0100785) | 2.64079180 |
44 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.60263177 |
45 | Pallor (HP:0000980) | 2.60016452 |
46 | Truncus arteriosus (HP:0001660) | 2.55213962 |
47 | Diplopia (HP:0000651) | 2.55192138 |
48 | Abnormality of binocular vision (HP:0011514) | 2.55192138 |
49 | Facial hemangioma (HP:0000329) | 2.54478400 |
50 | Ulnar bowing (HP:0003031) | 2.54187879 |
51 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.53440551 |
52 | Hypoparathyroidism (HP:0000829) | 2.48861419 |
53 | Abnormality of the aortic arch (HP:0012303) | 2.47078549 |
54 | Xanthomatosis (HP:0000991) | 2.46828664 |
55 | Annular pancreas (HP:0001734) | 2.46448488 |
56 | Abnormality of the gallbladder (HP:0005264) | 2.46176805 |
57 | Rib fusion (HP:0000902) | 2.42675858 |
58 | Cutaneous photosensitivity (HP:0000992) | 2.42175175 |
59 | Hypochromic microcytic anemia (HP:0004840) | 2.40247553 |
60 | Long palpebral fissure (HP:0000637) | 2.40247254 |
61 | Abnormal platelet volume (HP:0011876) | 2.38966877 |
62 | Paralysis (HP:0003470) | 2.38355937 |
63 | Gastrointestinal infarctions (HP:0005244) | 2.37146243 |
64 | Self-mutilation (HP:0000742) | 2.28739066 |
65 | Thoracic kyphosis (HP:0002942) | 2.28103153 |
66 | Hypercortisolism (HP:0001578) | 2.23212203 |
67 | Decreased subcutaneous fat (HP:0001002) | 2.23089387 |
68 | Microcytic anemia (HP:0001935) | 2.21999873 |
69 | Complete atrioventricular canal defect (HP:0001674) | 2.20809246 |
70 | Hypoplastic iliac wings (HP:0002866) | 2.20512242 |
71 | J-shaped sella turcica (HP:0002680) | 2.17694544 |
72 | Stridor (HP:0010307) | 2.16348355 |
73 | Papilloma (HP:0012740) | 2.14107231 |
74 | Verrucae (HP:0200043) | 2.14107231 |
75 | Squamous cell carcinoma (HP:0002860) | 2.13263759 |
76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11245531 |
77 | Obstructive lung disease (HP:0006536) | 2.11245531 |
78 | Cervical subluxation (HP:0003308) | 2.10368824 |
79 | Purpura (HP:0000979) | 2.08519580 |
80 | Macrocytic anemia (HP:0001972) | 2.07754613 |
81 | Abnormality of dental color (HP:0011073) | 2.07253259 |
82 | Increased mean platelet volume (HP:0011877) | 2.06902130 |
83 | Myopathic facies (HP:0002058) | 2.05815176 |
84 | Ileus (HP:0002595) | 2.04298701 |
85 | Agammaglobulinemia (HP:0004432) | 2.02792191 |
86 | Panhypogammaglobulinemia (HP:0003139) | 2.01601655 |
87 | Pustule (HP:0200039) | 2.01234443 |
88 | Emphysema (HP:0002097) | 2.00261727 |
89 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 11.3647788 |
90 | Acanthocytosis (HP:0001927) | 10.2203546 |
91 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99684166 |
92 | Thin ribs (HP:0000883) | 1.99387368 |
93 | Bowel incontinence (HP:0002607) | 1.98556250 |
94 | Supernumerary ribs (HP:0005815) | 1.96658512 |
95 | Intrahepatic cholestasis (HP:0001406) | 1.96297365 |
96 | Generalized hyperpigmentation (HP:0007440) | 1.96180525 |
97 | Joint stiffness (HP:0001387) | 1.96057277 |
98 | Hypercholesterolemia (HP:0003124) | 1.95738352 |
99 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.95688400 |
100 | Disproportionate tall stature (HP:0001519) | 1.94584334 |
101 | Pointed chin (HP:0000307) | 1.93560287 |
102 | Intestinal fistula (HP:0100819) | 1.92982460 |
103 | Spinal canal stenosis (HP:0003416) | 1.87858809 |
104 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.87321292 |
105 | Colitis (HP:0002583) | 1.85898982 |
106 | Nasal polyposis (HP:0100582) | 1.85675046 |
107 | Broad distal phalanx of finger (HP:0009836) | 1.85297515 |
108 | Lymphangioma (HP:0100764) | 1.84709857 |
109 | Abnormality of the columella (HP:0009929) | 1.84064358 |
110 | Biconcave vertebral bodies (HP:0004586) | 1.84025234 |
111 | Abnormality of the fingertips (HP:0001211) | 1.82911007 |
112 | Eczematoid dermatitis (HP:0000976) | 1.82600602 |
113 | Testicular atrophy (HP:0000029) | 1.81530022 |
114 | Menorrhagia (HP:0000132) | 1.81224334 |
115 | Dislocated radial head (HP:0003083) | 1.81151671 |
116 | Abnormal large intestine physiology (HP:0012700) | 1.79629567 |
117 | Breast hypoplasia (HP:0003187) | 1.79244484 |
118 | Vaginal fistula (HP:0004320) | 1.78334863 |
119 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.78056141 |
120 | Supernumerary nipples (HP:0002558) | 1.77182429 |
121 | Abnormality of the radial head (HP:0003995) | 1.76986675 |
122 | Gingival bleeding (HP:0000225) | 1.75569136 |
123 | Abnormality of the nasal mucosa (HP:0000433) | 1.74893885 |
124 | Short middle phalanx of finger (HP:0005819) | 1.72688024 |
125 | Abnormality of homocysteine metabolism (HP:0010919) | 1.71973144 |
126 | Homocystinuria (HP:0002156) | 1.71973144 |
127 | Gastrointestinal dysmotility (HP:0002579) | 1.71267748 |
128 | Gastrointestinal stroma tumor (HP:0100723) | 1.71021673 |
129 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.70762517 |
130 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.70762517 |
131 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.70762517 |
132 | Hypobetalipoproteinemia (HP:0003563) | 1.70467868 |
133 | Atelectasis (HP:0100750) | 1.70413485 |
134 | Hyperlipoproteinemia (HP:0010980) | 1.70141199 |
135 | Global brain atrophy (HP:0002283) | 1.67021401 |
136 | Osteomalacia (HP:0002749) | 1.65531465 |
137 | Joint hemorrhage (HP:0005261) | 1.64794187 |
138 | Cellulitis (HP:0100658) | 1.63921879 |
139 | Hypertriglyceridemia (HP:0002155) | 1.60285123 |
140 | Urticaria (HP:0001025) | 1.58733526 |
141 | Back pain (HP:0003418) | 1.57892169 |
142 | Abnormality of the Achilles tendon (HP:0005109) | 1.57885489 |
143 | Gastrointestinal inflammation (HP:0004386) | 1.57221256 |
144 | Easy fatigability (HP:0003388) | 1.56536745 |
145 | Multiple lipomas (HP:0001012) | 1.56474085 |
146 | Autoimmune thrombocytopenia (HP:0001973) | 1.52732632 |
147 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.51900222 |
148 | Basal cell carcinoma (HP:0002671) | 1.51128190 |
149 | Atrioventricular canal defect (HP:0006695) | 1.49763219 |
150 | Hepatocellular carcinoma (HP:0001402) | 1.44287872 |
151 | Thickened nuchal skin fold (HP:0000474) | 1.43615840 |
152 | Abnormality of the common coagulation pathway (HP:0010990) | 1.42419430 |
153 | Duodenal stenosis (HP:0100867) | 1.42355518 |
154 | Small intestinal stenosis (HP:0012848) | 1.42355518 |
155 | Hemorrhage of the eye (HP:0011885) | 1.42009705 |
156 | Achilles tendon contracture (HP:0001771) | 1.41953666 |
157 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.41570263 |
158 | Hyperacusis (HP:0010780) | 1.41552443 |
159 | Hypolipoproteinemia (HP:0010981) | 1.40502365 |
160 | Myocardial infarction (HP:0001658) | 1.40107580 |
161 | Prolonged partial thromboplastin time (HP:0003645) | 1.39412376 |
162 | Acrocyanosis (HP:0001063) | 1.38999967 |
163 | Spontaneous hematomas (HP:0007420) | 1.38934097 |
164 | Hypoalphalipoproteinemia (HP:0003233) | 1.38650872 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K10 | 6.13918105 |
2 | TRIB3 | 4.07604627 |
3 | PKN2 | 3.68228822 |
4 | PRPF4B | 3.59748401 |
5 | EEF2K | 3.54510895 |
6 | SMG1 | 3.16962686 |
7 | MAP4K1 | 2.99820626 |
8 | ICK | 2.47867939 |
9 | STK4 | 2.20591342 |
10 | ERN1 | 2.19347459 |
11 | GRK6 | 2.06508075 |
12 | IRAK3 | 1.91769589 |
13 | TAOK1 | 1.90734479 |
14 | MAP3K11 | 1.85138109 |
15 | MAPK11 | 1.84395214 |
16 | CDC7 | 1.77743653 |
17 | TNK2 | 1.76283937 |
18 | STK10 | 1.75920136 |
19 | SIK1 | 1.75860623 |
20 | CDK12 | 1.75032932 |
21 | NEK2 | 1.73881821 |
22 | CDK19 | 1.72052956 |
23 | TAOK3 | 1.64194373 |
24 | BMX | 1.61260673 |
25 | SIK2 | 1.58161831 |
26 | TAOK2 | 1.55171575 |
27 | CDK4 | 1.51159526 |
28 | KDR | 1.36749874 |
29 | IRAK2 | 1.34327070 |
30 | MAPK15 | 1.32340989 |
31 | DYRK3 | 1.29668533 |
32 | LRRK2 | 1.29634355 |
33 | MAP3K8 | 1.27122815 |
34 | ALK | 1.26926737 |
35 | PTK6 | 1.26704742 |
36 | RIPK4 | 1.20413393 |
37 | CDK6 | 1.18963655 |
38 | SCYL2 | 1.18381353 |
39 | EIF2AK1 | 1.16754576 |
40 | DYRK1B | 1.15065720 |
41 | IRAK4 | 1.14209964 |
42 | NME2 | 1.08002846 |
43 | BCKDK | 1.03970240 |
44 | RPS6KA2 | 1.03767618 |
45 | PIM1 | 1.03581370 |
46 | CDC42BPA | 0.99072379 |
47 | BLK | 0.97807390 |
48 | TYRO3 | 0.95626851 |
49 | MAP2K2 | 0.94717025 |
50 | BRSK1 | 0.94393385 |
51 | MTOR | 0.92815395 |
52 | AKT2 | 0.92390881 |
53 | PRKD3 | 0.92379838 |
54 | MKNK2 | 0.91922629 |
55 | RPS6KA1 | 0.88589196 |
56 | UHMK1 | 0.85924272 |
57 | MAP3K7 | 0.84566998 |
58 | RPS6KL1 | 0.84148915 |
59 | RPS6KC1 | 0.84148915 |
60 | JAK2 | 0.83983198 |
61 | RPS6KA6 | 0.83276882 |
62 | SIK3 | 0.81139008 |
63 | BUB1 | 0.80065333 |
64 | FLT3 | 0.77830694 |
65 | RPS6KB2 | 0.75919983 |
66 | TYK2 | 0.74729675 |
67 | EPHA2 | 0.70707113 |
68 | AURKA | 0.65933351 |
69 | RPS6KA4 | 0.65551140 |
70 | MAP3K3 | 0.65330338 |
71 | PAK4 | 0.63972024 |
72 | TBK1 | 0.63381914 |
73 | IKBKB | 0.62307920 |
74 | HIPK2 | 0.62166598 |
75 | RET | 0.61471870 |
76 | IKBKE | 0.61384781 |
77 | SYK | 0.60608910 |
78 | ZAP70 | 0.60020291 |
79 | MARK3 | 0.59862911 |
80 | TLK1 | 0.58729235 |
81 | PAK2 | 0.57979393 |
82 | CAMKK1 | 0.57623358 |
83 | MAPK12 | 0.56465386 |
84 | STK3 | 0.55420051 |
85 | MAP3K1 | 0.54397144 |
86 | STK16 | 0.54264651 |
87 | WNK4 | 0.53668443 |
88 | CHEK2 | 0.52800638 |
89 | MAP3K13 | 0.52047254 |
90 | SGK3 | 0.51808461 |
91 | PRKD2 | 0.51624579 |
92 | CHUK | 0.51251636 |
93 | PRKCH | 0.50871472 |
94 | CDK2 | 0.48752385 |
95 | FES | 0.48175469 |
96 | CLK1 | 0.48077737 |
97 | BTK | 0.48071981 |
98 | CDK9 | 0.47678355 |
99 | WNK1 | 0.46880327 |
100 | CHEK1 | 0.46632958 |
101 | MAPKAPK2 | 0.46210518 |
102 | TAF1 | 0.45962848 |
103 | PDPK1 | 0.45074947 |
104 | AKT1 | 0.44381264 |
105 | MAPK3 | 0.44129657 |
106 | MAP2K3 | 0.44127045 |
107 | STK11 | 0.44047899 |
108 | RPS6KA5 | 0.43213021 |
109 | PRKAA2 | 0.43132677 |
110 | HCK | 0.43084102 |
111 | MAPK4 | 0.42479806 |
112 | MAPK1 | 0.42431850 |
113 | FGFR4 | 0.40858051 |
114 | MELK | 0.40161963 |
115 | JAK3 | 0.40110180 |
116 | MARK2 | 0.39996919 |
117 | CDK7 | 0.39319158 |
118 | ATM | 0.38316271 |
119 | TTN | 0.37758224 |
120 | MAP2K1 | 0.37098272 |
121 | ITK | 0.36398799 |
122 | PRKG2 | 0.36199735 |
123 | PRKCI | 0.34012810 |
124 | PDK1 | 0.33795583 |
125 | CDK8 | 0.33392055 |
126 | NME1 | 0.32981923 |
127 | CAMK1D | 0.32860953 |
128 | DAPK3 | 0.32619560 |
129 | MAPK8 | 0.32113495 |
130 | PIM2 | 0.31808378 |
131 | DAPK2 | 0.31607954 |
132 | * CDK1 | 0.31530730 |
133 | BRAF | 0.30638276 |
134 | PRKAA1 | 0.30494421 |
135 | MUSK | 0.29474176 |
136 | CSK | 0.28886049 |
137 | PRKD1 | 0.28473642 |
138 | MST1R | 0.28448412 |
139 | PDK2 | 0.28116966 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 4.66641594 |
2 | Sulfur relay system_Homo sapiens_hsa04122 | 2.98381283 |
3 | Lysine degradation_Homo sapiens_hsa00310 | 2.94684173 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.63868586 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.55106995 |
6 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.55103588 |
7 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.49459530 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.45020055 |
9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.33163347 |
10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.23267210 |
11 | ABC transporters_Homo sapiens_hsa02010 | 2.06282042 |
12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.04744901 |
13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.04608524 |
14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.98789974 |
15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.85081681 |
16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.84915527 |
17 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.84803821 |
18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.76632472 |
19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.76533000 |
20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.76199607 |
21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.69865081 |
22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.68004170 |
23 | Bladder cancer_Homo sapiens_hsa05219 | 1.62010130 |
24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.61543990 |
25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.59064948 |
26 | Bile secretion_Homo sapiens_hsa04976 | 1.58089429 |
27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.55804088 |
28 | DNA replication_Homo sapiens_hsa03030 | 1.49003554 |
29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48544042 |
30 | Endometrial cancer_Homo sapiens_hsa05213 | 1.46872002 |
31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34029834 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.32287917 |
33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32218212 |
34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30385383 |
35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26934166 |
36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.25729445 |
37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.25410101 |
38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23888693 |
39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22488123 |
40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20746095 |
41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.20032327 |
42 | Cell cycle_Homo sapiens_hsa04110 | 1.19579791 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13751113 |
44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13392889 |
45 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.09508947 |
46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09406283 |
47 | Hepatitis C_Homo sapiens_hsa05160 | 1.06547788 |
48 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05329001 |
49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04860827 |
50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03836053 |
51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01807242 |
52 | Insulin resistance_Homo sapiens_hsa04931 | 1.00721795 |
53 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.00460035 |
54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00089980 |
55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.00011353 |
56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99780090 |
57 | Spliceosome_Homo sapiens_hsa03040 | 0.96436519 |
58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95966296 |
59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95814911 |
60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94847343 |
61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93366006 |
62 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93172245 |
63 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.92650476 |
64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91828787 |
65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.91095916 |
66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90646204 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90618255 |
68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89728859 |
69 | Alcoholism_Homo sapiens_hsa05034 | 0.89581254 |
70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89110608 |
71 | Prostate cancer_Homo sapiens_hsa05215 | 0.87610384 |
72 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85788012 |
73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85201316 |
74 | Prion diseases_Homo sapiens_hsa05020 | 0.84576245 |
75 | Hepatitis B_Homo sapiens_hsa05161 | 0.83657329 |
76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81802337 |
77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81424004 |
78 | Ribosome_Homo sapiens_hsa03010 | 0.81367872 |
79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.79423773 |
80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78788998 |
81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78774233 |
82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78488684 |
83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78330650 |
84 | Base excision repair_Homo sapiens_hsa03410 | 0.77592184 |
85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76468506 |
86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75189291 |
87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71221158 |
88 | Apoptosis_Homo sapiens_hsa04210 | 0.71119060 |
89 | Platelet activation_Homo sapiens_hsa04611 | 0.70849807 |
90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70063388 |
91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70005810 |
92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69182243 |
93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68729066 |
94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.68242563 |
95 | Glioma_Homo sapiens_hsa05214 | 0.67931572 |
96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67415119 |
97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65727367 |
98 | Influenza A_Homo sapiens_hsa05164 | 0.65573511 |
99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64847474 |
100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63870649 |
101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63396384 |
102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60528431 |
103 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58067746 |
104 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57907837 |
105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57898911 |
106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56515462 |
107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56237904 |
108 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56089987 |
109 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56045010 |
110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55937232 |
111 | Malaria_Homo sapiens_hsa05144 | 0.54621369 |
112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54508194 |
113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54026662 |
114 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53985321 |
115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53926514 |
116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52529734 |
117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52449759 |
118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52140506 |
119 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.51693161 |
120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50369077 |
121 | Peroxisome_Homo sapiens_hsa04146 | 0.50162295 |
122 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50132297 |
123 | Measles_Homo sapiens_hsa05162 | 0.50063563 |
124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48201169 |
125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47982301 |
126 | Tuberculosis_Homo sapiens_hsa05152 | 0.45837921 |
127 | Endocytosis_Homo sapiens_hsa04144 | 0.45737054 |
128 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45560235 |
129 | Melanoma_Homo sapiens_hsa05218 | 0.45265077 |
130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.44360910 |
131 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.43275506 |
132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42705061 |
133 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42464361 |
134 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42176176 |
135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41860634 |
136 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.41722092 |
137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41702898 |
138 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.41110353 |
139 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40985711 |
140 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40984208 |
141 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40075487 |
142 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40072997 |
143 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39854842 |
144 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39596803 |
145 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38795376 |
146 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38791194 |
147 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37393007 |
148 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34488336 |
149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34463345 |
150 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33528410 |